Progress Toward Improving Animal Models for Idiopathic Pulmonary Fibrosis
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis (IPF) remains a disease with an unknown cause and a poor prognosis. Among attempts to define disease pathogenesis, animal models of experimental lung fibrosis have a prominent role. Commonly used models include exposure to bleomycin, silica, fluorescein isothiocyanate; irradiation; or expression of specific genes through a viral vector or transgenic system. These all have been instrumental in the study of lung fibrosis, but all have limitations and fall short of recapitulating a pattern of usual interstitial pneumonia, the pathologic correlate to IPF. A model of repetitive bleomycin lung injury has recently been reported that results in marked lung fibrosis, prominent alveolar epithelial cell hyperplasia, a pattern of temporal heterogeneity and persistence of aberrant remodeling well after stimulus removal, representing a significant addition to the collection of animal lung fibrosis models. Taken together, animal models remain a key component in research strategies to better define IPF pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
Kim, C. F. B., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R. T., & Jacks, T. (2005) · Cell · doi:10.1016/j.cell.2005.03.032 · Cited by 2,195
Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605669103 · Cited by 1,257
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Moeller, A., Ask, K., Warburton, D., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.011 · Cited by 1,007
Gross, T. J., & Hunninghake, G. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003200 · Cited by 962
Murine models of pulmonary fibrosis
Moore, B. B., & Hogaboam, C. M. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00313.2007 · Cited by 796
Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., & Gauldie, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12568 · Cited by 753
Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
Piguet, P. F., Collart, M. A., Grau, G. E., Kapanci, Y., & Vassalli, P. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.655 · Cited by 583
Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis
Piguet, P. F., Collart, M. A., Grau, G. E., Sappino, A.-P., & Vassalli, P. (1990) · Nature · doi:10.1038/344245a0 · Cited by 454
Contribution of Epithelial-derived Fibroblasts to Bleomycin-induced Lung Fibrosis
Tanjore, H., Xu, X. C., Polosukhin, V. V., Degryse, A. L., Li, B., Han, W., Sherrill, T. P., Plieth, D., Neilson, E. G., Blackwell, T. S., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0322oc · Cited by 405
Self-citationKim, K. K., Wei, Y., Szekeres, C., Kugler, M. C., Wolters, P. J., Hill, M. L., Frank, J. A., Brumwell, A. N., Wheeler, S. E., Kreidberg, J. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36940 · Cited by 397
Miyazaki, Y., Araki, K., Vesin, C., Garcia, I., Kapanci, Y., Whitsett, J. A., Piguet, P. F., & Vassalli, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118029 · Cited by 370
Lee, C. G., Cho, S. J., Kang, M. J., Chapoval, S. P., Lee, P. J., Noble, P. W., Yehualaeshet, T., Lu, B., Flavell, R. A., Milbrandt, J., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040104 · Cited by 369
Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis
Degryse, A. L., Tanjore, H., Xu, X. C., Polosukhin, V. V., Jones, B. R., McMahon, F. B., Gleaves, L. A., Blackwell, T. S., & Lawson, W. E. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00026.2010 · Cited by 311
Self-citationThe Role of CCL12 in the Recruitment of Fibrocytes and Lung Fibrosis
Moore, B. B., Murray, L., Das, A., Wilke, C. A., Herrygers, A. B., & Toews, G. B. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0239oc · Cited by 309
Rübe, C. E., Uthe, D., Schmid, K. W., Richter, K. D., Wessel, J., Schuck, A., Willich, N., & Rübe, C. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00482-x · Cited by 282
Radiation and the lung: A reevaluation of the mechanisms mediating pulmonary injury
Morgan, G. W., Pharm, B., & Breit, S. N. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00477-3 · Cited by 275
Korfhagen, T. R., Swantz, R. J., Wert, S. E., McCarty, J. M., Kerlakian, C. B., Glasser, S. W., & Whitsett, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117152 · Cited by 191
Lawson, W. E., Polosukhin, V. V., Stathopoulos, G. T., Zoia, O., Han, W., Lane, K. B., Li, B., Donnelly, E. F., Holburn, G. E., Lewis, K. G., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61214-x · Cited by 174
Self-citationCharacterization of Fibroblast-specific Protein 1 in Pulmonary Fibrosis
Lawson, W. E., Polosukhin, V. V., Zoia, O., Stathopoulos, G. T., Han, W., Plieth, D., Loyd, J. E., Neilson, E. G., & Blackwell, T. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200311-1535oc · Cited by 173
Self-citationHoshino, T., Okamoto, M., Sakazaki, Y., Kato, S., Young, H. A., & Aizawa, H. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0182oc · Cited by 163
Role of Repeated Lung Injury and Genetic Background in Bleomycin-Induced Fibrosis
Chung, M. P., Monick, M. M., Hamzeh, N. Y., Butler, N. S., Powers, L. S., & Hunninghake, G. W. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0029oc · Cited by 135
Haston, C. K., & Travis, E. L. (1997) · PubMed · Cited by 119
The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis
Barbarin, V., Nihoul, A., Misson, P., Arras, M., Delos, M., Leclercq, I., Lison, D., & Huaux, F. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-112 · Cited by 112
Conditional expression of transforming growth factor-α in adult mouse lung causes pulmonary fibrosis
Hardie, W. D., Cras, T. D. L., Jiang, K., Tichelaar, J. W., Azhar, M., & Korfhagen, T. R. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00208.2003 · Cited by 110
Christensen, P. J., Goodman, R. E., Pastoriza, L., Moore, B. B., & Toews, G. B. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65493-4 · Cited by 95
Pulmonary toxicity of antitumor agents
Muggia, F. M., Louie, A. C., & Sikic, B. I. (1983) · Cancer Treatment Reviews · doi:10.1016/0305-7372(83)90012-9 · Cited by 84
Update in idiopathic pulmonary fibrosis
Frankel, S. K., & Schwarz, M. I. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32832ea4b3 · Cited by 72
Receptor-activated Smad localisation in Bleomycin-induced pulmonary fibrosis
Higashiyama, H., Yoshimoto, D., Okamoto, Y., Kikkawa, H., Asano, S., & Kinoshita, M. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.037606 · Cited by 40
Cited by
Type 2 alveolar cells are stem cells in adult lung
Barkauskas, C. E., Cronce, M. J., Rackley, C. R., Bowie, E. J., Keene, D. R., Stripp, B. R., Randell, S. H., Noble, P. W., & Hogan, B. L. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68782 · Cited by 1,776
Rock, J. R., Barkauskas, C. E., Cronce, M. J., Xue, Y., Harris, J. R., Liang, J., Noble, P. W., & Hogan, B. L. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117988108 · Cited by 1,030
Zepp, J. A., Zacharias, W. J., Frank, D. B., Cavanaugh, C. A., Zhou, S., Morley, M. P., & Morrisey, E. E. (2017) · Cell · doi:10.1016/j.cell.2017.07.034 · Cited by 567
The Flaws and Human Harms of Animal Experimentation
AKHTAR, A. (2015) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s0963180115000079 · Cited by 527
Targeting metabolic dysregulation for fibrosis therapy
Zhao, X., Kwan, J. Y. Y., Yip, K., Liu, P. P., & Liu, F.-F. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0040-5 · Cited by 513
Metadata
- Authors
- Degryse, A. L., & Lawson, W. E.
- Venue
- The American Journal of the Medical Sciences
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 341
- Issue
- 6
- Pages
- 444-449
- ISSN
- 0002-9629 (ISSN-L)
- OpenAlex
- W1976547976
- Cited by
- 162
- References
- 31
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.